Information Library
Results for: Lower portfolio & investment risks
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Partnering to Maximize Rewards in Pharmerging Markets
White Paper — September 15, 2011
In the past few years so-called “pharmerging” markets have been heralded as the hottest growth area for biopharmaceutical drugs. With large populations, growing disposable income and unmet medical needs, these markets have seen doubledigit growth rates in pharmaceutical spending. -
Translational R&D Services Fact Sheet
Brochure — May 26, 2011
Quintiles’ Translational R&D Center of Excellence performs groundbreaking research and offers novel findings in oncology for biopharmaceutical companies. -
Biomarkers in Alzheimers Disease
Presentation — March 17, 2011
The Quintiles Innovation Unit shares their knowledge on the use of biomarkers in compound development in clinical trials. -
Quintiles Supports Samsung's Entry into BioPharma Market through Joint Venture
Press Release — February 28, 2011 – The Samsung Group, South Korea’s largest industrial group, has entered into a strategic partnership with Quintiles, to support Samsung’s entry into the bio pharmaceuticals market.
-
Population PK/PD - Modeling and Simulation Optimization Tools
Brochure — February 11, 2011
Population pharmacokinetic/ pharmacodynamic (PK/PD) modeling and simulation, available from Quintiles, is now endorsed by the FDA as often being instrumental in drug approval and labeling. -
The New Health Alliance
White Paper — January 10, 2011
Biopharmaceutical companies must explore alternative strategic alliances that meet the needs of the New Health and produce medicines that demonstrate value to the entire constellation of stakeholders. -
Consulting – Breakthrough Thinking Built on Experience
Brochure — November 23, 2010
Consulting at Quintiles brings a critical element to engagements: fresh thinking built on a full lifecycle understanding of biopharma realities today. -
Reinventing Safety
Brochure — September 22, 2010
When you integrate all your safety information, you can make better decisions, navigate regulatory hurdles and get to market faster. -
Safety Strategy & Optimization
Brochure — September 14, 2010
Learn how to enable your safety group to become a value-added contributor throughout the product lifecycle. -
Managing Pharmacovigilance as a Business
White Paper — July 28, 2010
The three steps required to develop a strategic approach to global capacity management.